The agency’s nonbinding recommendation points to the same risk posed by power morcellators — the inadvertent dispersion of occult cancer. ACOG disagrees with the new guidance.
News Alerts …read more
The agency’s nonbinding recommendation points to the same risk posed by power morcellators — the inadvertent dispersion of occult cancer. ACOG disagrees with the new guidance.
News Alerts …read more